Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.380
-0.270 (-5.81%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $50.84 million as of April 28, 2026. Its market cap has increased by 66.90% in one year.
Market Cap
50.84M
Enterprise Value
24.77M
1-Year Change
66.90%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $50.84M, a decrease of -30.21%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 50.84M | -13.98% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 54.63M |
| MiNK Therapeutics | 54.38M |
| Kezar Life Sciences | 54.15M |
| Entera Bio | 52.22M |
| PDS Biotechnology | 50.26M |
| Atossa Therapeutics | 49.08M |
| Nutriband | 48.57M |
| Telomir Pharmaceuticals | 48.13M |